Keywords: generics, firms, take, merck, co, pepcid, finally

Generics firms take on Merck & Co's Pepcid

Article | 17 April 2001

Print This

Merck & Co has finally lost patent protection on its gastrointestinaldrug Pepcid (famotidine) in the USA, with a string of companies ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in